Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A

Fabiola Atzeni, P. Sarzi-Puttini, F. Capsoni, L. Vulpio, M. Carrabba

Research output: Contribution to journalArticlepeer-review

Abstract

We report a patient with longstanding systemic lupus erythematosus (SLE) who developed pure red cell aplasia (PRCA). This condition is rare in connective tissue diseases and is reported in 32 previous cases of SLE in literature. Our patient recovered, apparently in response to treatment with high dosage of corticosteroids, but relapse occurred when the prednisone dosage was tapered down to 10 mg/day. The patient was successfully treated with cyclosporin A with no recurrence of the disease in the last 2 years.

Original languageEnglish
Pages (from-to)759-762
Number of pages4
JournalClinical and Experimental Rheumatology
Volume21
Issue number6
Publication statusPublished - Nov 2003

Keywords

  • Cyclosporin A
  • Pure red cell aplasia
  • SLE

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Fingerprint

Dive into the research topics of 'Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A'. Together they form a unique fingerprint.

Cite this